Advancing Knowledge,
Improving Patient Outcomes
AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.
CE Courses
Program Overview
This CME program will provide clinicians with an update regarding the safety and efficacy of JAK inhibitor therapeutics for the treatment of atopic dermatitis. The expert faculty, led by Dr. Lawrence F. Eichenfield, will first outline current clinical trial data for JAK-1 inhibitor therapeutics in atopic dermatitis (AD), encompassing topics such as difficulties living with AD and the ...View Course
Program Overview
Areas of North America and Western Europe have struggled with repeated waves and emerging variants of SARS CoV-2 infection. Even as some countries and regions strive to return to pre-pandemic behavior, the COVID-19 pandemic continues to exert many deleterious effects on the delivery of continuing healthcare for many vulnerable populations. Those affected include patients who would be expected ...View Course
Program Overview
This CME/CE program will highlight recent advances in the treatment and management of patients with relapsed/refractory multiple myeloma (RRMM). The expert faculty, led by C. Ola Landgren, MD, will first discuss best practices for integrating BCMA-targeted therapy into treatment plans for patients with RRMM. Following, emerging therapies in relapsed and remitting multiple myeloma will be reviewed, analyzing both ...View Course
Program Overview
This CME/CE program is derived from content presented at the ACTRIMS Forum 2022. The educational activity, chaired by Fred D. Lublin, MD, will analyze best practices for incorporating sphingosine 1 phosphate (S1P) therapeutics in treatment plans for patients with multiple sclerosis (MS). The expert faculty will first outline the pathophysiology and specific science of all S1P receptor modulators ...View Course
Program Overview
This CME/CE program will highlight optimal guideline directed medical therapy for patients with heart failure (HF). The expert faculty will first review current ACC/AHA and ESC recommendations for directed medical therapy to treat patients with heart failure with reduced ejection fraction (HFrEF). Following, the faculty will analyze clinical trial data for SGLT2is, vericiguat, and omecamtiv mecarbil therapeutics. Next, ...View Course
Program Overview
This CME post-conference review and analysis will highlight therapeutic advances in the management of patients with gastrointestinal cancer, including data presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022. The expert faculty will analyze the latest therapeutic advances for the treatment and management of gastrointestinal (GI) cancer as presented at ASCO GI 2022. They ...View Course
Upcoming Events
